Pfizer gets OK for $43-billion Seagen deal after donating cancer drug rights
(Reuters) – Pfizer said on Tuesday it has agreed to donate the rights of royalties from sales of cancer drug…
S&P 500, Nasdaq subdued at open after inflation data
(Reuters) – The S&P 500 and Nasdaq were muted at the open on Tuesday as the latest inflation reading turned…
Corporate buybacks continue to accelerate
Corporate buybacks are experiencing a notable acceleration, marking the second-largest inflows since 2009 and surpassing seasonal levels for the fifth…
RBC Capital upgrades Amgen on ‘improving position of stability’ and diminishing uncertainty
RBC Capital lifted its rating for Amgen (NASDAQ:AMGN) to Outperform from Sector Perform in a note Tuesday, raising the price…
Moderna chief commercial officer steps down
(Reuters) – U.S. drugmaker Moderna (NASDAQ:MRNA) said on Tuesday Chief Commercial Officer (CCO) Arpa Garay has stepped down more than…
Uncovering the potential of Wall Street’s biotech star
In the dynamic world of biopharmaceuticals, Regeneron (NASDAQ:REGN) Pharmaceuticals, Inc. stands out as a beacon of innovation and resilience. The…
India stocks lower at close of trade; Nifty 50 down 0.43%
India stocks were lower after the close on Tuesday, as losses in the Oil & Gas, Real Estate and Power…
Oil rises after Houthi attack on ship, weak sentiment weighs
(Reuters) – Oil rose on Tuesday as an attack by the Iran-aligned Houthis on a chemical tanker escalated geopolitical tension…
Illumina slams EU for over-extending power to assess Grail deal
(Reuters) – Illumina (NASDAQ:ILMN) on Tuesday slammed EU antitrust regulators for over-extending their powers when they scrutinised the U.S. life…
Citi says bullish flow support is returning to markets
Citigroup strategists observe a resurgence of bullish momentum in both U.S. and European stocks after two weeks of slowing futures…